{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:27:47Z","timestamp":1790663267452,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00262-021-03037-9","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:08:13Z","timestamp":1630685293000},"page":"875-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations"],"prefix":"10.1007","volume":"71","author":[{"given":"Thibault","family":"Comont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Nicolau-Travers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Recher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-4534","authenticated-orcid":false,"given":"Emmanuel","family":"Treiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"3","key":"3037_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3):453\u201374","journal-title":"Blood"},{"issue":"1","key":"3037_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2015-08-604520","volume":"127","author":"H Dombret","year":"2016","unstructured":"Dombret H, Gardin C (2016) An update of current treatments for adult acute myeloid leukemia. Blood 127(1):53\u201361","journal-title":"Blood"},{"issue":"5","key":"3037_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","volume":"4","author":"M Bleakley","year":"2004","unstructured":"Bleakley M, Riddell SR (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 4(5):371\u2013380","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3037_CR4","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/leu.2012.145","volume":"26","author":"S Anguille","year":"2012","unstructured":"Anguille S, Van Tendeloo VF, Berneman ZN (2012) Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Leukemia 26(10):2186\u201396","journal-title":"Leukemia"},{"issue":"9","key":"3037_CR5","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.4049\/jimmunol.1103710","volume":"188","author":"J Gertner-Dardenne","year":"2012","unstructured":"Gertner-Dardenne J, Castellano R, Mamessier E, Garbit S, Kochbati E, Etienne A et al (2012) Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol 188(9):4701\u20138","journal-title":"J Immunol"},{"issue":"12","key":"3037_CR6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0145-2126(87)90158-5","volume":"11","author":"E Lotzova","year":"1987","unstructured":"Lotzova E, Savary CA, Herberman RB (1987) Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. Leuk Res 11(12):1059\u20131066","journal-title":"Leuk Res"},{"issue":"4","key":"3037_CR7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.2002.03495.x","volume":"117","author":"MW Lowdell","year":"2002","unstructured":"Lowdell MW, Craston R, Samuel D, Wood ME, O\u2019Neill E, Saha V et al (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. Br J Haematol 117(4):821\u2013827","journal-title":"Br J Haematol"},{"key":"3037_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","volume":"103","author":"R Austin","year":"2016","unstructured":"Austin R, Smyth MJ, Lane SW (2016) Harnessing the immune system in acute myeloid leukaemia. Crit Rev Oncol Hematol 103:62\u201377","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"3037_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.leu.2404032","volume":"20","author":"D Behl","year":"2006","unstructured":"Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC et al (2006) Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 20(1):29\u201334","journal-title":"Leukemia"},{"issue":"9","key":"3037_CR10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2009.05.015","volume":"15","author":"K Le Blanc","year":"2009","unstructured":"Le Blanc K, Barrett AJ, Schaffer M, Hagglund H, Ljungman P, Ringden O et al (2009) Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant 15(9):1108\u20131115","journal-title":"Biol Blood Marrow Transplant"},{"key":"3037_CR11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3389\/fimmu.2019.01997","volume":"10","author":"L Minculescu","year":"2019","unstructured":"Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS et al (2019) Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of tcr gamma delta cells 2 months after allogeneic stem cell transplantation. Front Immunol 10:1997","journal-title":"Front Immunol"},{"issue":"4","key":"3037_CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2011.08.007","volume":"18","author":"MD Thoma","year":"2012","unstructured":"Thoma MD, Huneke TJ, DeCook LJ, Johnson ND, Wiegand RA, Litzow MR et al (2012) Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 18(4):600\u20137","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3037_CR13","doi-asserted-by":"crossref","first-page":"e0156777","DOI":"10.1371\/journal.pone.0156777","volume":"11","author":"DM Tian","year":"2016","unstructured":"Tian DM, Wang Y, Zhang XH, Liu KY, Huang XJ, Chang YJ (2016) Rapid Recovery of CD3+CD8+ T cells on day 90 predicts superior survival after unmanipulated haploidentical blood and marrow transplantation. PLoS One. 11(6):e0156777","journal-title":"PLoS One."},{"issue":"7","key":"3037_CR14","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.18632\/oncotarget.7210","volume":"7","author":"FE Sander","year":"2016","unstructured":"Sander FE, Rydstrom A, Bernson E, Kiffin R, Riise R, Aurelius J et al (2016) Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia. Oncotarget 7(7):7586\u201396","journal-title":"Oncotarget"},{"issue":"7","key":"3037_CR15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1078-0432.CCR-19-3003","volume":"26","author":"L Tang","year":"2020","unstructured":"Tang L, Wu J, Li CG, Jiang HW, Xu M, Du M et al (2020) Characterization of immune dysfunction and identification of prognostic immune-related risk factors in acute myeloid leukemia. Clin Cancer Res 26(7):1763\u201372","journal-title":"Clin Cancer Res"},{"key":"3037_CR16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","volume":"11","author":"TSC Hinks","year":"2020","unstructured":"Hinks TSC, Zhang XW (2020) MAIT cell activation and functions. Front Immunol 11:1014","journal-title":"Front Immunol"},{"key":"3037_CR17","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/ncomms4866","volume":"5","author":"M Lepore","year":"2014","unstructured":"Lepore M, Kalinichenko A, Colone A, Paleja B, Singhal A, Tschumi A et al (2014) Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire. Nat Commun 5:3866","journal-title":"Nat Commun"},{"issue":"12","key":"3037_CR18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1084\/jem.189.12.1907","volume":"189","author":"F Tilloy","year":"1999","unstructured":"Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H et al (1999) An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha\/beta T cell subpopulation in mammals. J Exp Med 189(12):1907\u20131921","journal-title":"J Exp Med"},{"key":"3037_CR19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fimmu.2020.01961","volume":"11","author":"AJ Corbett","year":"2020","unstructured":"Corbett AJ, Awad W, Wang H, Chen Z (2020) Antigen recognition by MR1-reactive T cells; MAIT cells, metabolites, and remaining mysteries. Front Immunol 11:1961","journal-title":"Front Immunol"},{"issue":"7426","key":"3037_CR20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L et al (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491(7426):717\u201323","journal-title":"Nature"},{"issue":"6928","key":"3037_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","volume":"422","author":"E Treiner","year":"2003","unstructured":"Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F et al (2003) Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422(6928):164\u2013169","journal-title":"Nature"},{"issue":"1","key":"3037_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/mi.2016.39","volume":"10","author":"Z Chen","year":"2016","unstructured":"Chen Z, Wang H, D\u2019Souza C, Sun S, Kostenko L, Eckle SB et al (2016) Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol 10(1):58\u201368","journal-title":"Mucosal Immunol"},{"issue":"12","key":"3037_CR23","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.celrep.2019.08.050","volume":"28","author":"T Leng","year":"2019","unstructured":"Leng T, Akther HD, Hackstein CP, Powell K, King T, Friedrich M et al (2019) TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions. Cell Rep 28(12):3077\u201391 e5","journal-title":"Cell Rep"},{"key":"3037_CR24","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3389\/fimmu.2020.02097","volume":"11","author":"M Pavlovic","year":"2020","unstructured":"Pavlovic M, Gross C, Chili C, Secher T, Treiner E (2020) MAIT cells display a specific response to type 1 IFN underlying the adjuvant effect of TLR7\/8 ligands. Front Immunol 11:2097","journal-title":"Front Immunol"},{"key":"3037_CR25","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.1038\/srep20358","volume":"6","author":"L Ling","year":"2016","unstructured":"Ling L, Lin Y, Zheng W, Hong S, Tang X, Zhao P et al (2016) Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients. Sci Rep 6:20358","journal-title":"Sci Rep"},{"issue":"7","key":"3037_CR26","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","volume":"195","author":"P Sundstrom","year":"2015","unstructured":"Sundstrom P, Ahlmanner F, Akeus P, Sundquist M, Alsen S, Yrlid U et al (2015) Human Mucosa-Associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-gamma. J Immunol 195(7):3472\u201381","journal-title":"J Immunol"},{"issue":"12","key":"3037_CR27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00262-015-1764-7","volume":"64","author":"L Zabijak","year":"2015","unstructured":"Zabijak L, Attencourt C, Guignant C, Chatelain D, Marcelo P, Marolleau JP et al (2015) Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients. Cancer Immunol Immunother 64(12):1601\u20138","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"3037_CR28","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1158\/1078-0432.CCR-18-3040","volume":"25","author":"M Duan","year":"2019","unstructured":"Duan M, Goswami S, Shi JY, Wu LJ, Wang XY, Ma JQ et al (2019) Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma. Clin Cancer Res 25(11):3304\u201316","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3037_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tjog.2018.11.022","volume":"58","author":"WC Huang","year":"2019","unstructured":"Huang WC, Hsiao YC, Wu CC, Hsu YT, Chang CL (2019) Less circulating mucosal-associated invariant T cells in patients with cervical cancer. Taiwan J Obstet Gynecol 58(1):117\u201321","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"6","key":"3037_CR30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/ijc.33411","volume":"148","author":"Z Lu","year":"2021","unstructured":"Lu Z, Zhu M, Marley JL, Bi K, Wang K, Zhai M et al (2021) The combined action of monocytic myeloid-derived suppressor cells and mucosal-associated invariant T cells promotes the progression of cervical cancer. Int J Cancer 148(6):1499\u20131507. https:\/\/doi.org\/10.1002\/ijc.33411","journal-title":"Int J Cancer"},{"key":"3037_CR31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2019.01580","volume":"10","author":"AM Melo","year":"2019","unstructured":"Melo AM, O\u2019Brien AM, Phelan JJ, Kennedy SA, Wood NAW, Veerapen N et al (2019) Mucosal-associated invariant T cells display diminished effector capacity in oesophageal adenocarcinoma. Front Immunol 10:1580","journal-title":"Front Immunol"},{"issue":"46","key":"3037_CR32","doi-asserted-by":"crossref","first-page":"76274","DOI":"10.18632\/oncotarget.11187","volume":"7","author":"EJ Won","year":"2016","unstructured":"Won EJ, Ju JK, Cho YN, Jin HM, Park KJ, Kim TJ et al (2016) Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer. Oncotarget 7(46):76274\u201390","journal-title":"Oncotarget"},{"issue":"29","key":"3037_CR33","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.18632\/oncotarget.26866","volume":"10","author":"P Sundstrom","year":"2019","unstructured":"Sundstrom P, Szeponik L, Ahlmanner F, Sundquist M, Wong JSB, Lindskog EB et al (2019) Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules. Oncotarget 10(29):2810\u201323","journal-title":"Oncotarget"},{"issue":"1","key":"3037_CR34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2159-8290.CD-19-0569","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan J, Allen S, McDonald E, Das I, Mak JYW, Liu L et al (2020) MAIT cells promote tumor initiation, growth, and metastases via tumor MR1. Cancer Discov 10(1):124\u201341","journal-title":"Cancer Discov"},{"issue":"12","key":"3037_CR35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00262-018-2132-1","volume":"67","author":"SMM Haeryfar","year":"2018","unstructured":"Haeryfar SMM, Shaler CR, Rudak PT (2018) Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe? Cancer Immunol Immunother 67(12):1885\u201396","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"3037_CR36","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41598-018-22130-1","volume":"8","author":"NA Gherardin","year":"2018","unstructured":"Gherardin NA, Loh L, Admojo L, Davenport AJ, Richardson K, Rogers A et al (2018) Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma. Sci Rep 8(1):4159","journal-title":"Sci Rep"},{"issue":"1","key":"3037_CR37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12185-018-2442-2","volume":"108","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Umeda K, Hiejima E, Iwai A, Mikami M, Nodomi S et al (2018) Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation. Int J Hematol 108(1):66\u201375","journal-title":"Int J Hematol"},{"key":"3037_CR38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3389\/fimmu.2017.01861","volume":"8","author":"M Solders","year":"2017","unstructured":"Solders M, Erkers T, Gorchs L, Poiret T, Remberger M, Magalhaes I et al (2017) Mucosal-associated invariant T cells display a poor reconstitution and altered phenotype after allogeneic hematopoietic stem cell transplantation. Front Immunol 8:1861","journal-title":"Front Immunol"},{"issue":"3","key":"3037_CR39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354\u2013365","journal-title":"Blood"},{"issue":"12","key":"3037_CR40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41408-017-0011-1","volume":"7","author":"S Bertoli","year":"2017","unstructured":"Bertoli S, Tavitian S, Huynh A, Borel C, Guenounou S, Luquet I et al (2017) Improved outcome for AML patients over the years 2000\u20132014. Blood Cancer J 7(12):635","journal-title":"Blood Cancer J"},{"issue":"12","key":"3037_CR41","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1002\/ajh.23848","volume":"89","author":"P Bories","year":"2014","unstructured":"Bories P, Bertoli S, Berard E, Laurent J, Duchayne E, Sarry A et al (2014) Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network. Am J Hematol 89(12):E244-52","journal-title":"Am J Hematol"},{"issue":"32","key":"3037_CR42","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2018.78.7366","volume":"36","author":"A Pigneux","year":"2018","unstructured":"Pigneux A, Bene MC, Salmi LR, Dumas PY, Delaunay J, Bonmati C et al (2018) Improved survival by adding lomustine to conventional chemotherapy for elderly patients with AML without unfavorable cytogenetics: results of the LAM-SA 2007 FILO trial. J Clin Oncol 36(32):3203\u201310","journal-title":"J Clin Oncol"},{"issue":"4","key":"3037_CR43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u201347","journal-title":"Blood"},{"issue":"4","key":"3037_CR44","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","volume":"117","author":"M Dusseaux","year":"2011","unstructured":"Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250\u20139","journal-title":"Blood"},{"issue":"13","key":"3037_CR45","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","volume":"113","author":"BJ Wouters","year":"2009","unstructured":"Wouters BJ, Lowenberg B, Erpelinck-Verschueren CA, van Putten WL, Valk PJ, Delwel R (2009) Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 113(13):3088\u20133091","journal-title":"Blood"},{"issue":"21","key":"3037_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120974","volume":"3","author":"HA Knaus","year":"2018","unstructured":"Knaus HA, Berglund S, Hackl H, Blackford AL, Zeidner JF, Montiel-Esparza R et al (2018) Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight 3(21):e120974. https:\/\/doi.org\/10.1172\/jci.insight.120974","journal-title":"JCI Insight"},{"key":"3037_CR47","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/bcj.2015.58","volume":"5","author":"Y Kong","year":"2015","unstructured":"Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Zhu L et al (2015) PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. Blood Cancer J 5:e330","journal-title":"Blood Cancer J"},{"issue":"18","key":"3037_CR48","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood-2009-02-206946","volume":"114","author":"R Le Dieu","year":"2009","unstructured":"Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, Fatah R et al (2009) Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood 114(18):3909\u20133916","journal-title":"Blood"},{"issue":"18","key":"3037_CR49","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1038\/s41388-020-1239-y","volume":"39","author":"Z Li","year":"2020","unstructured":"Li Z, Philip M, Ferrell PB (2020) Alterations of T-cell-mediated immunity in acute myeloid leukemia. Oncogene 39(18):3611\u20139","journal-title":"Oncogene"},{"issue":"6","key":"3037_CR50","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25791","volume":"129","author":"Z Shenghui","year":"2011","unstructured":"Shenghui Z, Yixiang H, Jianbo W, Kang Y, Laixi B, Yan Z et al (2011) Elevated frequencies of CD4(+) CD25(+) CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer 129(6):1373\u201381","journal-title":"Int J Cancer"},{"issue":"9","key":"3037_CR51","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/cncr.31896","volume":"125","author":"P Williams","year":"2018","unstructured":"Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE et al (2018) The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer 125(9):1470\u201381","journal-title":"Cancer"},{"issue":"2","key":"3037_CR52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04011.x","volume":"158","author":"C Wu","year":"2009","unstructured":"Wu C, Wang S, Wang F, Chen Q, Peng S, Zhang Y et al (2009) Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol 158(2):199\u2013204","journal-title":"Clin Exp Immunol"},{"key":"3037_CR53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fonc.2019.01162","volume":"9","author":"LM Mendez","year":"2019","unstructured":"Mendez LM, Posey RR, Pandolfi pp. (2019) The interplay between the genetic and immune landscapes of AML: mechanisms and implications for risk stratification and therapy. Front Oncol 9:1162","journal-title":"Front Oncol"},{"issue":"3","key":"3037_CR54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3):225\u201334","journal-title":"Cancer Cell"},{"issue":"3","key":"3037_CR55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2013.12.016","volume":"14","author":"LM Kats","year":"2014","unstructured":"Kats LM, Reschke M, Taulli R, Pozdnyakova O, Burgess K, Bhargava P et al (2014) Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell 14(3):329\u201341","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3037_CR56","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1172\/JCI90644","volume":"127","author":"G Kohanbash","year":"2017","unstructured":"Kohanbash G, Carrera DA, Shrivastav S, Ahn BJ, Jahan N, Mazor T et al (2017) Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest 127(4):1425\u201337","journal-title":"J Clin Invest"},{"issue":"7","key":"3037_CR57","doi-asserted-by":"crossref","first-page":"e1445454","DOI":"10.1080\/2162402X.2018.1445454","volume":"7","author":"M Bottcher","year":"2018","unstructured":"Bottcher M, Renner K, Berger R, Mentz K, Thomas S, Cardenas-Conejo ZE et al (2018) D-2-hydroxyglutarate interferes with HIF-1alpha stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization. Oncoimmunology 7(7):e1445454","journal-title":"Oncoimmunology"},{"issue":"8","key":"3037_CR58","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","volume":"24","author":"L Bunse","year":"2018","unstructured":"Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M et al (2018) Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat Med 24(8):1192\u2013203","journal-title":"Nat Med"},{"issue":"8","key":"3037_CR59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1101\/gad.294991.116","volume":"31","author":"NM Amankulor","year":"2017","unstructured":"Amankulor NM, Kim Y, Arora S, Kargl J, Szulzewsky F, Hanke M et al (2017) Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev 31(8):774\u201386","journal-title":"Genes Dev"},{"issue":"52","key":"3037_CR60","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1617929114","volume":"113","author":"F Lemonnier","year":"2016","unstructured":"Lemonnier F, Cairns RA, Inoue S, Li WY, Dupuy A, Broutin S et al (2016) The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development. Proc Natl Acad Sci U S A 113(52):15084\u20139","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3037_CR61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20171739","volume":"215","author":"G Ben Youssef","year":"2018","unstructured":"Ben Youssef G, Tourret M, Salou M, Ghazarian L, Houdouin V, Mondot S et al (2018) Ontogeny of human mucosal-associated invariant T cells and related T cell subsets. J Exp Med 215(2):459\u201379","journal-title":"J Exp Med"},{"issue":"2","key":"3037_CR62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbmt.2017.10.003","volume":"24","author":"A Bhattacharyya","year":"2018","unstructured":"Bhattacharyya A, Hanafi LA, Sheih A, Golob JL, Srinivasan S, Boeckh MJ et al (2018) Graft-derived reconstitution of mucosal-associated invariant T cells after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 24(2):242\u201351","journal-title":"Biol Blood Marrow Transplant"},{"key":"3037_CR63","doi-asserted-by":"crossref","first-page":"556695","DOI":"10.3389\/fimmu.2020.556695","volume":"11","author":"GM Swarbrick","year":"2020","unstructured":"Swarbrick GM, Gela A, Cansler ME, Null MD, Duncan RB, Nemes E et al (2020) Postnatal expansion, maturation, and functionality of MR1T cells in humans. Front Immunol 11:556695","journal-title":"Front Immunol"},{"issue":"7","key":"3037_CR64","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/cancers12071974","volume":"12","author":"L Dekker","year":"2020","unstructured":"Dekker L, de Koning C, Lindemans C, Nierkens S (2020) Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation. Cancers (Basel) 12(7):1974. https:\/\/doi.org\/10.3390\/cancers12071974","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3037_CR65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10238-015-0384-z","volume":"16","author":"J Novak","year":"2015","unstructured":"Novak J, Dobrovolny J, Brozova J, Novakova L, Kozak T (2015) Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation. Clin Exp Med 16(4):529\u201337","journal-title":"Clin Exp Med"},{"issue":"1","key":"3037_CR66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2567.2002.01400.x","volume":"106","author":"FF Fagnoni","year":"2002","unstructured":"Fagnoni FF, Lozza L, Zibera C, Zambelli A, Ponchio L, Gibelli N et al (2002) T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence. Immunology 106(1):27\u201337","journal-title":"Immunology"},{"issue":"3","key":"3037_CR67","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2008-01-132464","volume":"112","author":"SJ Lin","year":"2008","unstructured":"Lin SJ, Chen AT, Welsh RM (2008) Immune system derived from homeostatic proliferation generates normal CD8 T-cell memory but altered repertoires and diminished heterologous immune responses. Blood 112(3):680\u2013689","journal-title":"Blood"},{"issue":"5","key":"3037_CR68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","volume":"21","author":"E Velardi","year":"2021","unstructured":"Velardi E, Tsai JJ, van den Brink MRM (2021) T cell regeneration after immunological injury. Nat Rev Immunol 21(5):277\u2013291. https:\/\/doi.org\/10.1038\/s41577-020-00457-z","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3037_CR69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/sji.12193","volume":"80","author":"J Novak","year":"2014","unstructured":"Novak J, Dobrovolny J, Novakova L, Kozak T (2014) The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80(4):271\u20135","journal-title":"Scand J Immunol"},{"issue":"4","key":"3037_CR70","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood-2012-09-456095","volume":"121","author":"S Gerart","year":"2013","unstructured":"Gerart S, Siberil S, Martin E, Lenoir C, Aguilar C, Picard C et al (2013) Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood 121(4):614\u201323","journal-title":"Blood"},{"key":"3037_CR71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fimmu.2019.00260","volume":"10","author":"P Chen","year":"2019","unstructured":"Chen P, Deng W, Li D, Zeng T, Huang L, Wang Q et al (2019) Circulating mucosal-associated invariant T cells in a large cohort of healthy Chinese individuals from newborn to elderly. Front Immunol 10:260","journal-title":"Front Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-03037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-021-03037-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-021-03037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T13:23:00Z","timestamp":1647264180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-021-03037-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1007\/s00262-021-03037-9","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.C received honoraria and\/or research or educational support from AbbVie, AstraZeneca, Bristol Myers Squibb (Celgene), Novartis and Takeda. S.B. has served on advisory boards for Daiichi-Sankyo, Astellas, Sanofi, and Jazz Pharmaceuticals. CR received research grants (my institution) by Abbvie, Amgen, Novartis, Celgene, Jazz Pharma, Agios, Daiichi-Sankyo, Astellas, Roche, MaatPharma; and has served on advisory boards for Abbvie, Janssen, Jazz Pharma, Daiichi-Sankyo, Astellas, Novartis, Celgene, Takeda, Roche, Otsuka, Macrogenics, Pfizer. F.V received research support from Pierre-Fabre. Other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Blood samples from healthy donors were obtained through a convention between the Etablissement Fran\u00e7ais du Sang (EFS)\u2014Midi-Pyr\u00e9n\u00e9es and the University Hospital of Toulouse. Patients with AML gave their written consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}